Abstract |
Epidemiological studies suggest potent anticancer effects of tea catechins. Previously, we have reported (I. Naasani et aL, Biochem. Biophys. Res. Commun., 249: 391-396, 1998) that epigallocatechin gallate (EGCG), a major tea catechin, strongly and directly inhibits telomerase, a ribonucleoprotein that maintains telomeres and has been implicated in tumorigenesis. Here, we describe newly synthesized compounds MST-312, MST-295, and MST-199, as more effective telomerase inhibitors than EGCG. Continuous treatment of human monoblastoid leukemia U937 cells with a nontoxic dose of each drug caused progressive telomere shortening and eventual reduction of growth rate accompanied by induction of the senescence-associated beta-galactosidase activity. Particularly, in the case of MST-312, the effective dose required for the telomere shortening was 1-2 microM, which was 15- to 20-fold lower than that of EGCG. These compounds may provide a novel chemotherapeutic strategy for the treatment of cancers.
|
Authors | Hiroyuki Seimiya, Tomoko Oh-hara, Tsuneji Suzuki, Imad Naasani, Toshiyuki Shimazaki, Katsutoshi Tsuchiya, Takashi Tsuruo |
Journal | Molecular cancer therapeutics
(Mol Cancer Ther)
Vol. 1
Issue 9
Pg. 657-65
(Jul 2002)
ISSN: 1535-7163 [Print] United States |
PMID | 12479362
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Benzamides
- Chromones
- Enzyme Inhibitors
- MST 199
- MST 295
- MST 312
- Catechin
- epigallocatechin gallate
- Telomerase
- beta-Galactosidase
|
Topics |
- Antineoplastic Agents
(therapeutic use)
- Apoptosis
- Benzamides
(therapeutic use)
- Blotting, Southern
- Catechin
(analogs & derivatives, therapeutic use)
- Chromones
(therapeutic use)
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
(therapeutic use)
- Humans
- Models, Chemical
- Phenotype
- Telomerase
(antagonists & inhibitors)
- Telomere
(physiology)
- Time Factors
- U937 Cells
- beta-Galactosidase
(metabolism)
|